"At Del Sol Research our mission is to ensure the highest level of care and safety for our patients through their participation in each clinical trial in order to deliver an optimal patient experience. In addition we strive to provide high quality data to aid in the development and approval of cutting edge medications to improve quality of life for individuals with a variety of medical conditions."

During the past decade, Del Sol Research Management, LLC conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 17 clinical trials were completed, i.e. on average, 44.7% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 16 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Del Sol Research Management, LLC" #1 sponsor was "Allergan" with 4 trials, followed by "Phathom Pharmaceuticals, Inc." with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Del Sol Research Management, LLC" #1 collaborator was "Chemo Research" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Del Sol Research Management, LLC" are "Eosinophilic Esophagitis" (5 trials), "Crohn's Disease" (4 trials), "Gastroparesis" (4 trials), "Colorectal Cancer" (3 trials) and "Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Del Sol Research Management, LLC" in a lesser frequency.

Most popular intervention types in "Del Sol Research Management, LLC" are "Drug" (32 trials), "Device" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Vonoprazan" (4 trials), "Relamorelin" (3 trials), "APT-1011" (2 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Del Sol Research Management, LLC" are 36 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Del Sol Research Management, LLC". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Del Sol Research Management, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Del Sol Research Management, LLC, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".